Clinical and Microbiologic Variables Predictive of Orthopedic Complications Following Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children
- PMID: 30753346
- PMCID: PMC7348234
- DOI: 10.1093/cid/ciz109
Clinical and Microbiologic Variables Predictive of Orthopedic Complications Following Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children
Abstract
Background: Staphylococcus aureus is the most common cause of acute hematogenous osteoarticular infections (AHOAIs) in children. The risk factors for the development of orthopedic complications (OC) after AHOAI are poorly understood. We sought to describe clinical and microbiologic variables present on the index admission that may predict OC in S. aureus AHOAI.
Methods: Staphylococcus aureus AHOAI cases were identified from 2011-2017 at Texas Children's Hospital and reviewed for the development of OC. OC included chronic osteomyelitis, growth arrest, avascular necrosis, chronic dislocation, and pathologic fracture. All S. aureus isolates were characterized by pulsed-field gel electrophoresis and agr group.
Results: A total of 286 cases were examined of which 27 patients (9.4%) developed OC. Patients who developed OC more often had infection with an agr group III organism (P = .04), bacteremia (P = .04), delayed source control (P < .001), ≥2 surgical procedures (P < .001), intensive care unit admission (P = .09), and fever >4 days after admission (P = .008). There was no association with OC and patient age, methicillin resistance, or choice/route of antibiotics. In multivariable analyses of OC, infection with agr group III S. aureus, prolonged fever, and delayed source control remained statistically significant.
Conclusions: OC develop following S. aureus AHOAI in 9.4% of cases. Although the development of OC is likely multifactorial, agr group III organisms, prolonged fever, and delayed source control are independently associated with OC. Moreover, early aggressive surgical source control may be beneficial in children with S. aureus AHOAI.
Keywords: agr III; chronic osteomyelitis; osteomyelitis; pediatric; source control.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Similar articles
-
The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection.Pediatr Infect Dis J. 2017 Jun;36(6):572-577. doi: 10.1097/INF.0000000000001503. Pediatr Infect Dis J. 2017. PMID: 28027279 Free PMC article.
-
Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.J Clin Microbiol. 2006 Feb;44(2):595-7. doi: 10.1128/JCM.44.2.595-597.2006. J Clin Microbiol. 2006. PMID: 16455920 Free PMC article.
-
Association of Vancomycin MIC and Molecular Characteristics with Clinical Outcomes in Methicillin-Susceptible Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children.Antimicrob Agents Chemother. 2018 Apr 26;62(5):e00084-18. doi: 10.1128/AAC.00084-18. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29530845 Free PMC article.
-
Predictive Factors to Guide Empiric Antimicrobial Therapy of Acute Hematogenous Osteomyelitis in Children.Pediatr Infect Dis J. 2023 Jun 1;42(6):449-455. doi: 10.1097/INF.0000000000003875. Epub 2023 Feb 16. Pediatr Infect Dis J. 2023. PMID: 36795576 Review.
-
Metastatic infection during Staphylococcus aureus bacteremia.J Infect Chemother. 2020 Feb;26(2):162-169. doi: 10.1016/j.jiac.2019.10.003. Epub 2019 Oct 30. J Infect Chemother. 2020. PMID: 31676266 Review.
Cited by
-
Clinical outcomes of pediatric osteomyelitis.BMC Pediatr. 2023 Feb 3;23(1):54. doi: 10.1186/s12887-023-03863-z. BMC Pediatr. 2023. PMID: 36732705 Free PMC article.
-
Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management.Infect Drug Resist. 2020 Dec 14;13:4459-4473. doi: 10.2147/IDR.S257517. eCollection 2020. Infect Drug Resist. 2020. PMID: 33364793 Free PMC article. Review.
-
Vancomycin Therapeutic Drug Monitoring in Children: New Recommendations, Similar Challenges.J Pediatr Pharmacol Ther. 2020;25(6):472-475. doi: 10.5863/1551-6776-25.6.472. J Pediatr Pharmacol Ther. 2020. PMID: 32839650 Free PMC article.
-
Linear programming based gene expression model (LPM-GEM) predicts the carbon source for Bacillus subtilis.BMC Bioinformatics. 2022 Jun 10;23(1):226. doi: 10.1186/s12859-022-04742-7. BMC Bioinformatics. 2022. PMID: 35689204 Free PMC article.
-
Predictive value of PAR and PNI for the acute complicated course of pediatric acute hematogenous osteomyelitis.J Pediatr (Rio J). 2024 Sep-Oct;100(5):533-538. doi: 10.1016/j.jped.2024.04.002. Epub 2024 Apr 25. J Pediatr (Rio J). 2024. PMID: 38677322 Free PMC article.
References
-
- McNeil JC, Forbes AR, Vallejo JG, et al. . Role of operative or interventional radiology-guided cultures for osteomyelitis. Pediatrics 2016; 137:e20154616. - PubMed
-
- Arnold SR, Elias D, Buckingham SC, et al. . Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop 2006; 26:703–8. - PubMed
-
- Martínez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO Jr, Kaplan SL. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004; 23:701–6. - PubMed
-
- Dich VQ, Nelson JD, Haltalin KC. Osteomyelitis in infants and children. A review of 163 cases. Am J Dis Child 1975; 129:1273–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical